Body mass index and treatment survival in patients with RA starting treatment with TNFα-inhibitors: long-term follow-up in the real-life METEOR registry.
Sytske Anne BergstraCornelia F AllaartDavid Vega-MoralesMarieke De BuckElizabeth MurphyKaren Salomon EscotoThomas Wj HuizingaPublished in: RMD open (2021)
Both underweight and overweight patients discontinued TNFi treatment earlier than normal weight patients, without evidence of reported pain as the main determinant. It remains uncertain what determines TNFi survival in individual patients.